🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

PACS Group, Inc.

PACS Healthcare
$32.12 +$1.74 (5.73%)
Market Cap: $5.05 B
Gurus Holding
4
Popularity Rank
#2408
% of Shares Held
0.56%
Net Activity (Q4 2025)
-$45.71 M

Guru Ownership Trend

Guru Analysis for PACS Group, Inc. (PACS)

PACS Group, Inc. (PACS), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $28.29 M.

Top institutional holders include Chuck Royce and Cliff Asness.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $45.71 M net outflow during the quarter.

Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 89.8%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$521,874
Total Buy Value
New Buys 1
Additions 0
-$46.24 M
Total Sell Value
Reductions 3
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
3
Net Buyers
1

FAQs for PACS Group, Inc. (PACS)

Major holders include Chuck Royce ($28.65 M), Cliff Asness ($4.28 M), Steven Cohen ($521,874). According to the latest reported data, 4 tracked investment managers collectively hold approximately 880,636 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $45.71 M, with 1 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited PACS. The total reported sell value was $46.24 M.

Yes, 1 managers opened new positions in PACS, and 0 increased their existing holdings. The total reported buy value was $521,874.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.29% Reduce -59.9% 746,234 $28.65 M Q4 2025
0.00% Reduce -8.9% 111,608 $4.28 M Q4 2025
0.00% New Buy 13,594 $521,874 Q4 2025
0.00% Reduce -89.8% 9,200 $353,188 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form